These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21884306)

  • 41. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
    Scattoni V; Montironi R; Mazzucchelli R; Freschi M; Nava L; Losa A; Terrone C; Scarpa RM; Montorsi F; Pappagallo G; Rigatti P
    BJU Int; 2006 Jul; 98(1):54-8. PubMed ID: 16831143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
    Kronz JD; Shaikh AA; Epstein JI
    Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate lesions with cribriform / pseudocribriform pattern.
    Dema A; Borda A; Lazăr E; Lăzureanu C; Tăban S; Anderco D; Cornianu M; Mureşan A; Herman D; Loghin A; Cornea R; Faur A
    Rom J Morphol Embryol; 2010; 51(3):413-25. PubMed ID: 20809015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium.
    Amin MB; Bostwick DG
    Mod Pathol; 1996 Jul; 9(7):791-5. PubMed ID: 8832564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular features distinguishing benign and malignant phenotypes in prostatic biopsies.
    Foster CS
    Hum Pathol; 2000 Dec; 31(12):1445-7. PubMed ID: 11150368
    [No Abstract]   [Full Text] [Related]  

  • 49. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
    Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
    Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of basal cell markers used in the prostate.
    Freeman A; Treurnicht K; Munson P; Miller K; Parkinson MC
    Histopathology; 2002 May; 40(5):492-4. PubMed ID: 12010376
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intraductal carcinoma of prostate: diagnostic criteria and differential diagnosis].
    Cheng L; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):199-202. PubMed ID: 24842024
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosis of prostatic carcinoma after therapy.
    Bostwick DG; Meiers I
    Arch Pathol Lab Med; 2007 Mar; 131(3):360-71. PubMed ID: 17516739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostatic intraepithelial neoplasia: the preinvasive stage of prostate cancer. Overview of the prostate committee report.
    Bostwick DG; Norlén BJ; Denis L
    Scand J Urol Nephrol Suppl; 2000; (205):1-2. PubMed ID: 11144889
    [No Abstract]   [Full Text] [Related]  

  • 54. Atypical small acinar proliferations.
    Wightman HR
    Am J Surg Pathol; 1999 Apr; 23(4):489-91. PubMed ID: 10199483
    [No Abstract]   [Full Text] [Related]  

  • 55. Perils of hidden depths.
    Mason AE; Varma M
    J Clin Pathol; 2021 May; 74(5):e8. PubMed ID: 33132216
    [No Abstract]   [Full Text] [Related]  

  • 56. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
    Shibata MA; Jorcyk CL; Liu ML; Yoshidome K; Gold LG; Green JE
    Toxicol Pathol; 1998; 26(1):177-82. PubMed ID: 9502400
    [No Abstract]   [Full Text] [Related]  

  • 57. Primary adenosquamous carcinoma of the prostate: a rare aggressive tumor.
    Mishra S; Goel H; Awasthi N; Puri A; Mahapatra R; Pal DK
    Clin Genitourin Cancer; 2014 Feb; 12(1):e29-31. PubMed ID: 24145000
    [No Abstract]   [Full Text] [Related]  

  • 58. Cervical-type squamous metaplasia and myoepithelial cell differentiation in stromal tumor of the prostate.
    Montironi R; Lopez-Beltran A; Cheng L; Scarpelli M
    Am J Surg Pathol; 2011 Nov; 35(11):1752-4. PubMed ID: 21989353
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cancer of the prostate with metastases to the bone marrow].
    Tachev S; Ormanov I; Slavov Ch
    Khirurgiia (Sofiia); 1986; 39(5):96-7. PubMed ID: 3784403
    [No Abstract]   [Full Text] [Related]  

  • 60. Focal prostatic atrophy: morphologic classification and immunohistochemistry.
    Billis A; Piaza AC; Meirelles L; Freitas LL
    Anal Quant Cytopathol Histpathol; 2014 Apr; 36(2):71-81. PubMed ID: 24902359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.